Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
35.67
-0.33 (-0.92%)
At close: Oct 23, 2026, 4:00 PM EDT
35.72
+0.05 (0.15%)
After-hours: Oct 23, 2026, 7:57 PM EDT
Definium Therapeutics Employees
As of December 31, 2025, Definium Therapeutics had 106 total employees, including 105 full-time and 1 part-time employees. The number of employees increased by 32 or 43.24% compared to the previous year. That makes Definium Therapeutics the 31,147th largest employer in the world and 3,985th in the United States.
Employees
106
Change (1Y)
32
Growth (1Y)
43.24%
Revenue / Employee
n/a
Profits / Employee
-$3,337,594
Market Cap
4.79B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 106 | 32 | 43.24% | 105 | 1 |
| Dec 31, 2024 | 74 | 17 | 29.82% | 74 | 0 |
| Dec 31, 2023 | 57 | 9 | 18.75% | 57 | 0 |
| Dec 31, 2022 | 48 | 7 | 17.07% | 48 | 0 |
| Dec 31, 2021 | 41 | 19 | 86.36% | 41 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| CRISPR Therapeutics AG | 393 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| Tango Therapeutics | 137 |
| Edgewise Therapeutics | 127 |
DFTX News
- 10 days ago - Definium Therapeutics Announces New Employee Inducement Grants - Business Wire
- 14 days ago - Definium Therapeutics initiated with an Overweight at JPMorgan - TheFly
- 4 weeks ago - Definium Therapeutics Transcript: TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit - Transcripts
- 5 weeks ago - Definium Therapeutics Slides: Corporate presentation - Filings
- 5 weeks ago - Definium Therapeutics price target raised to $78 from $64 at Canaccord - TheFly
- 5 weeks ago - Definium Therapeutics price target raised to $79 from $75 at Baird - TheFly
- 5 weeks ago - Definium Therapeutics price target raised to $75 from $70 at Oppenheimer - TheFly
- 5 weeks ago - Definium Therapeutics price target raised to $91 from $75 at BofA - TheFly